Analysts’ Top Healthcare Picks: Ionis Pharmaceuticals (IONS), CVRx (CVRX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ionis Pharmaceuticals (IONS – Research Report), CVRx (CVRX – Research Report) and Solid Biosciences (SLDB – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ionis Pharmaceuticals (IONS)
In a report released yesterday, Myles Minter from William Blair reiterated a Buy rating on Ionis Pharmaceuticals. The company’s shares closed last Monday at $81.66.
According to TipRanks.com, Minter is a 5-star analyst with an average return of
Ionis Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $92.67, representing a 15.1% upside. In a report issued on January 7, TipRanks – Google also upgraded the stock to Buy with a $95.00 price target.
See today’s best-performing stocks on TipRanks >>
CVRx (CVRX)
William Blair analyst Brandon Vazquez maintained a Buy rating on CVRx yesterday. The company’s shares closed last Monday at $7.31, close to its 52-week low of $6.40.
According to TipRanks.com, Vazquez is a 4-star analyst with an average return of
Currently, the analyst consensus on CVRx is a Strong Buy with an average price target of $12.67.
Solid Biosciences (SLDB)
William Blair analyst Sami Corwin maintained a Buy rating on Solid Biosciences yesterday. The company’s shares closed last Monday at $5.24.
According to TipRanks.com, Corwin is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Solid Biosciences with a $14.88 average price target.
